Europe Radiopharmaceuticals Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Radiopharmaceuticals Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Radiopharmaceuticals Market Regional Analysis

6.2 Europe Radiopharmaceuticals Market Revenue 2019-2028 (US$ Million)

6.3 Europe Radiopharmaceuticals Market Forecast Analysis

7. Europe Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostic Nuclear Medicine

7.1.1 Overview
7.1.2 Diagnostic Nuclear Medicine: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Therapeutic Nuclear Medicine

7.2.1 Overview
7.2.2 Therapeutic Nuclear Medicine: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Radiopharmaceuticals Market Analysis – by Application

8.1 Oncology

8.1.1 Overview
8.1.2 Oncology: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Neurology

8.3.1 Overview
8.3.2 Neurology: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Radiopharmaceuticals Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Imaging Centers

9.2.1 Overview
9.2.2 Imaging Centers: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Academic and Research Centers

9.3.1 Overview
9.3.2 Academic and Research Centers: Europe Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Radiopharmaceuticals Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Radiopharmaceuticals Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.1.2 UK: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.1.3 UK: Europe Radiopharmaceuticals Market Breakdown, by End User

10.2.1.2 Germany: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.2.2 Germany: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Radiopharmaceuticals Market Breakdown, by End User

10.2.1.3 France: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.3.2 France: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.3.3 France: Europe Radiopharmaceuticals Market Breakdown, by End User

10.2.1.4 Russia: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.4.2 Russia: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Radiopharmaceuticals Market Breakdown, by End User

10.2.1.5 Italy: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.5.2 Italy: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Radiopharmaceuticals Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by Type
10.2.1.6.2 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Advanced Accelerator Applications

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bayer AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bracco Imaging S.p.A

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cardinal Health Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Curium

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 GENERAL ELECTRIC

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lantheus Medical Imaging, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Nordion

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 NTP RADIOISOTOPES

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Radiopharmaceuticals Market

Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)